文献速递肝胆胰外科围术期管理与 ERAS

减重手术同期行腹腔镜胆囊切除术的短期结局:2015-2021年MBSAQIP数据库分析

Concomitant laparoscopic cholecystectomy with bariatric surgery: current insights from the 2015-2021 MBSAQIP database.
PubMed 文献 · Surg Endosc · 2025-08-27

基于MBSAQIP数据库2015-2021年数据,分析852,640例袖状胃切除术(SG)和336,838例Roux-en-Y胃旁路术(RYGB)患者,其中同期行腹腔镜胆囊切除术(LC)者分别为1.0%和1.6%。经熵平衡和多变量回归调整后,同期LC与计划外插管和表浅手术部位感染风险升高相关,但未增加围手术期死亡率、再手术、漏或消化道出血风险。

要点

  • 同期LC与SG和RYGB术后计划外插管风险升高独立相关(AOR分别为2.01和2.27)。
  • 同期LC与表浅手术部位感染风险升高相关(SG-LC AOR 2.01;RYGB-LC AOR 1.41)。
  • 同期LC未增加围手术期死亡率、再手术、漏或消化道出血风险。

核心结论

  • 在风险调整后,减重手术同期行LC具有较好的安全性,与围手术期死亡率无关。
  • 同期LC与计划外插管和表浅手术部位感染风险升高相关,但绝对差异很小。

研究设计与样本

  • 回顾性队列研究,使用2015-2021年MBSAQIP数据库。
  • 纳入852,640例SG和336,838例RYGB患者,其中SG-LC 8705例(1.0%),RYGB-LC 5343例(1.6%)。
  • 采用熵平衡调整基线特征,多变量加权 logistic 和线性回归评估30天结局。

主要发现

  • SG-LC vs SG-only:表浅SSI 0.6% vs 0.3%(p<0.001),计划外插管0.3% vs 0.1%(p=0.001),肺炎0.3% vs 0.1%(p=0.042)。
  • RYGB-LC vs RYGB-only:感染性休克0.3% vs 0.2%(p=0.040),再手术3.5% vs 2.7%(p=0.009),计划外插管0.6% vs 0.3%(p=0.007)。
  • 调整后计划外插管AOR:SG-LC 2.01(95%CI 1.03-3.01),RYGB-LC 2.27(95%CI 1.17-4.40)。
  • 调整后表浅SSI AOR:SG-LC 2.01(95%CI 1.35-3.01),RYGB-LC 1.41(95%CI 1.01-1.98)。
  • RYGB-LC感染性休克AOR 2.83(95%CI 1.46-5.48)。

临床怎么用

  • 对于拟行减重手术且合并胆囊疾病的患者,同期LC总体安全,但需告知计划外插管和表浅SSI风险略有增加。
  • RYGB同期LC时需特别关注感染性休克和再手术风险,尽管绝对发生率低。

局限性

  • 回顾性 registry 研究,可能存在未测量混杂。
  • 事件发生率低,绝对差异小,临床意义需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity and cholelithiasis frequently coexist, leading to the consideration of combining bariatric surgery with laparoscopic cholecystectomy (LC) to address both conditions in a single procedure. This study analyzed short-term outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) with concomitant LC using MBSAQIP registry data. METHODS: Adults undergoing primary SG or RYGB, with and without concomitant LC (SG-LC and SG-only or RYGB-LC and RYGB-only, respectively), were analyzed from the 2015-2021 MBSAQIP database. Differences in baseline characteristics by LC status for each bariatric procedure were adjusted using entropy balancing. Multivariable weighted logistic and linear regressions were developed to evaluate the independent association between concomitant LC and 30-day outcomes of interest. RESULTS: Of 852,640 patients who underwent SG, 8705 (1.0%) received concomitant LC, while 5343 (1.6%) of 336,838 RYGB patients underwent concomitant LC. Compared to SG-only, SG-LC patients had significantly higher 30-day rates of superficial SSI (0.6% vs. 0.3%, p < 0.001), unplanned intubation (0.3% vs 0.1%, p = 0.001), and pneumonia (0.3% vs. 0.1%, p = 0.042). RYGB-LC patients experienced higher rates of septic shock (0.3% vs. 0.2%, p = 0.040), reoperation (3.5% vs. 2.7%, p = 0.009), and unplanned intubation (0.6% vs. 0.3%, p = 0.007) than RYGB-only. These were rare events with little absolute difference between LC and non-LC cohorts. Adjusted multivariate analyses confirmed increased odds of unplanned intubation (SG-LC: AOR 2.01, 95% CI 1.03-3.01; RYGB-LC: AOR 2.27, 95% CI 1.17-4.40) and superficial SSI (SG-LC: AOR 2.01, 95% CI 1.35-3.01; RYGB-LC: AOR 1.41, 95% CI 1.01-1.98) in both LC cohorts, as well as septic shock (AOR 2.83, 95% CI 1.46-5.48) among RYGB-LC. Neither SG-LC nor RYGB-LC demonstrated an association with perioperative mortality, reoperation, leakage, or gastrointestinal bleeding. CONCLUSIONS: In this 7-year registry study of over 1 million patients, bariatric surgery with concomitant LC demonstrated a favorable safety profile with no association with perioperative mortality after risk adjustment.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Rouhi AD, Leon S, Rosen CB, et al. Concomitant laparoscopic cholecystectomy with bariatric surgery: current insights from the 2015-2021 MBSAQIP database. Surg Endosc. 2025. PMID: 40866591. doi:10.1007/s00464-025-12051-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。